These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8069893)

  • 1. [The effect of polyene phosphatidylcholine (Essentiale forte) in the treatment of liver steatosis and ultrasound findings--preliminary study].
    Horejsová M; Urban J
    Cas Lek Cesk; 1994 Jun; 133(12):366-9. PubMed ID: 8069893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma proteins in patients with liver steatosis and the effect of treatment of essential phospholipids].
    Turecký L; Kupcová V; Szántová M; Laktis K; Uhlíková E
    Bratisl Lek Listy; 1996 Oct; 97(10):625-8. PubMed ID: 9019346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipid parameters in patients with alcoholic fatty liver after treatment with essential phospholipids.
    Turecky L; Kupcova V; Szantova M; Uhlikova E
    Bratisl Lek Listy; 2003; 104(7-8):227-31. PubMed ID: 15168868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up.
    Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Brzozowski T; Konturek SJ; Korolczuk A
    J Physiol Pharmacol; 2014 Feb; 65(1):75-82. PubMed ID: 24622832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
    Loguercio C; Andreone P; Brisc C; Brisc MC; Bugianesi E; Chiaramonte M; Cursaro C; Danila M; de Sio I; Floreani A; Freni MA; Grieco A; Groppo M; Lazzari R; Lobello S; Lorefice E; Margotti M; Miele L; Milani S; Okolicsanyi L; Palasciano G; Portincasa P; Saltarelli P; Smedile A; Somalvico F; Spadaro A; Sporea I; Sorrentino P; Vecchione R; Tuccillo C; Del Vecchio Blanco C; Federico A
    Free Radic Biol Med; 2012 May; 52(9):1658-65. PubMed ID: 22343419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis.
    Cichoz-Lach H; Celinski K; Konturek PC; Konturek SJ; Slomka M
    J Physiol Pharmacol; 2010 Oct; 61(5):577-80. PubMed ID: 21081801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Profiles of Five Essential Phospholipid Preparations for the Treatment of Nonalcoholic Fatty Liver Disease: A Comparative Study.
    Lüchtenborg C; Niederhaus B; Brügger B; Popovic B; Fricker G
    Lipids; 2020 May; 55(3):271-278. PubMed ID: 32255515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of the nutritional status of vitamin A and the regression of hepatic steatosis after Roux-en-Y gastric bypass surgery for treatment of class III obesity.
    Oliveira e Silva LG; Manso JE; Silva RA; Pereira SE; Saboya Sobrinho CJ; Rangel CW
    Arq Bras Cir Dig; 2012; 25(4):250-6. PubMed ID: 23411924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of focal sparing in hepatic steatosis.
    Kratzer W; Akinli AS; Bommer M; Arnold F; Eggink S; Imhof A; Mason RA; Klaus J; Schuler A; Boehm BO; Haenle MM
    Ultraschall Med; 2010 Feb; 31(1):37-42. PubMed ID: 20157869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with long-term administration of "essential" phospholipids in chronic active hepatitis. Review of 3 double-blind studies].
    Ilic V; Kordac V; Alvarez SZ
    Cas Lek Cesk; 1992 Dec; 131(26):801-4. PubMed ID: 1288892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile].
    Vakhrushev IaM; Suchkova EV; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
    Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R
    Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of essential phospholipids on liver injury due to total parenteral nutrition].
    Lata J; Dastych M; Senkyrík M; Husová M; Starý K
    Vnitr Lek; 2001 Sep; 47(9):599-603. PubMed ID: 11715663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of methionine, selenomethionine, and vitamin E on liver metabolic pathways and steatosis in high-cholesterol fed rabbits.
    Birkner E; Zalejska-Fiolka J; Kasperczyk A; Kasperczyk S; Grucka-Mamczar E; Stawiarska-Pieta B; Birkner K
    Biol Trace Elem Res; 2007; 120(1-3):179-94. PubMed ID: 17916970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detectable hypoechogenic images in diffuse hepatic steatosis: a new ultrasonic finding in the differential diagnosis of expansive lesions of the liver].
    Pia G; Aresu G; Pascalis L
    Minerva Med; 1990; 81(7-8):529-34. PubMed ID: 2199852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of polyene phosphatidylcholine administration on lipid metabolism and glucose tolerance in patients with hyperlipoproteinemia IIB].
    Zeman M; Zák A; Stolba P
    Sb Lek; 1995; 96(1):43-8. PubMed ID: 8711365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive effects of essential phospholipids and improvement of life style in patients with toxic liver injury].
    Holomán J; Glasa J; Hlavatý I; Veningerová M; Prachar V; Lukácsová M
    Bratisl Lek Listy; 1998 Feb; 99(2):75-81. PubMed ID: 9588082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential phospholipids in the treatment of hepatic encephalopathy].
    Brůha R; Marecek Z
    Vnitr Lek; 2000 Apr; 46(4):199-204. PubMed ID: 11227171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polyunsaturated phosphatidylcholine in the treatment of hepatic steatosis].
    Caruso L; Trischitta C; Bertino G; Amore MG; Rapisarda F; Calcara G
    Clin Ter; 1983 Nov; 107(4):279-90. PubMed ID: 6230201
    [No Abstract]   [Full Text] [Related]  

  • 20. Consumption of a whey protein-enriched diet may prevent hepatic steatosis associated with weight gain in elderly women.
    Ooi EM; Adams LA; Zhu K; Lewis JR; Kerr DA; Meng X; Solah V; Devine A; Binns CW; Prince RL
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):388-95. PubMed ID: 25638597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.